海南自贸港生物医药招商推介会在南京举办

Core Insights - The Hainan Free Trade Port is promoting its advantages in the biopharmaceutical industry through a recent investment promotion conference held in Nanjing, focusing on policy benefits and development opportunities [1] Group 1: Event Overview - The conference attracted nearly a hundred participants, including government representatives, industry experts, and executives from well-known biopharmaceutical companies [1] - The event featured policy interpretations, park promotions, corporate sharing, and interactive exchanges to showcase Hainan's institutional innovations and investment potential in the biopharmaceutical sector [1] Group 2: Investment Opportunities - The investment promotion segment detailed the overall progress of Hainan Free Trade Port's construction, unique policy advantages, and key layouts in the biopharmaceutical field [1] - Representatives from various organizations, including Haikou National High-tech Zone and Boao Lecheng International Medical Tourism Pilot Zone, presented investment development opportunities in the biopharmaceutical industry [1] Group 3: Industry Insights - Company representatives from firms such as Xiansheng Pharmaceutical, Mengyang Pharmaceutical, and Xinnuo Biotech engaged in in-depth discussions on topics like the transfer of innovative drug industries, internationalization of traditional Chinese medicine, and RNA drug research and development [1]